Related Experiment Video
Updated: May 11, 2026

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
Elevated systemic inflammation response index is associated with poor outcomes in minor ischemic stroke
Jie Li1,2, Ping Zhang1,2, Hong Chen1,2
1Department of Neurology, Deyang People's Hospital, Deyang, China.
Objectives:
Patients with minor ischemic stroke (MIS) have substantial disability rates at 90 days. Our study aimed to explore the association between the systemic inflammation response index (SIRI) and 3-month functional outcomes in patients with MIS.
Methods:
We conducted a prospective observational study in patients with MIS [defined as a National Institutes of Health Stroke Scale (NIHSS) score of 0-3] admitted within 24 h from symptoms onset. Blood samples for the SIRI measurement were collected on admission. The primary outcome measure was poor outcomes at 90 days (defined as a modified Rankin Scale score of 2-6). Univariate and multivariate logistic analyses were performed to assess the association between the SIRI and the risk of 3-month poor outcomes.
Results:
A total of 152 patients with MIS were enrolled, of which 24 cases (15.8%) had poor outcomes at 90 days. The median SIRI level was 1.27 [interquartile range (IQR), 0.77-1.92, ×10^9 /L] on admission. MIS patients with poor outcomes had higher levels of the SIRI than patients with good outcomes (poor outcomes: median, 1.93, IQR: 1.17-3.28, ×10^9 /L; good outcomes: median, 1.21, IQR: 0.71-1.80, ×10^9 /L; p = 0.003). The high SIRI level group (SIRI >1.27 × 10^9 /L) had significantly higher rates of poor outcomes at 90 days (22.4% vs. 9.2%, p = 0.026). After adjusting for age, baseline NIHSS score, prehospital delay, Trial of Org 10,172 in Acute Stroke Treatment (TOAST) classification, and other confounders in multivariate analyses, an elevated SIRI level remained independently associated with an increased risk of poor outcomes in patients with MIS [odds ratio (OR): 1.57, 95% confidence interval (CI): 1.12-2.20; p = 0.010]. Meanwhile, a high level of the SIRI (>1.27 × 10^9/L) was still an independent risk factor for 3-month poor outcomes (OR: 4.80, 95%CI: 1.51-15.29; p = 0.008) in MIS patients.
Conclusion:
Disability at 90 days was common in patients with MIS. An elevated SIRI was associated with poor outcomes in MIS patients. The SIRI might be a promising biomarker candidate that can help identify high-risk MIS patients with poor outcomes for reaching individual therapeutic decisions in clinical trials.
Insights
Elevated systemic inflammation response index (SIRI) levels are linked to poor 90-day functional outcomes in patients with minor ischemic stroke (MIS). SIRI may help identify high-risk MIS patients for personalized treatment strategies.
Area of Science:
- Neurology
- Inflammation Research
- Biomarker Discovery
Background:
- Minor ischemic stroke (MIS) frequently leads to significant long-term disability.
- Identifying early indicators of poor functional outcomes in MIS patients is crucial for timely intervention.
Purpose of the Study:
- To investigate the association between the systemic inflammation response index (SIRI) and 3-month functional outcomes in patients diagnosed with MIS.
- To determine if SIRI can serve as a predictive biomarker for disability after MIS.
Main Methods:
- A prospective observational study enrolled 152 MIS patients (NIHSS score 0-3) within 24 hours of symptom onset.
- Systemic inflammation response index (SIRI) was measured from blood samples collected upon admission.
- Functional outcomes were assessed at 90 days using the modified Rankin Scale (mRS), with scores 2-6 indicating poor outcomes.
Main Results:
- 15.8% of MIS patients experienced poor outcomes at 90 days.
- Patients with poor outcomes exhibited significantly higher median SIRI levels (1.93) compared to those with good outcomes (1.21) (p=0.003).
- An elevated SIRI (>1.27 × 10^9/L) was independently associated with an increased risk of poor 90-day outcomes (OR: 1.57, p=0.010) and a significant risk factor (OR: 4.80, p=0.008) in multivariate analysis.
Conclusions:
- Elevated SIRI levels are common in MIS patients and are significantly associated with poor functional outcomes at 90 days.
- The SIRI demonstrates potential as a valuable biomarker for identifying MIS patients at higher risk of disability.
- Utilizing SIRI could aid in tailoring therapeutic decisions and stratifying patients in clinical trials for MIS.
More Related Videos
Related Concept Videos
Inflammatory Response I: Vascular and Cellular
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Local and Systemic Effects
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

